Cargando…
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
With the increasing use of immune checkpoint inhibitors (ICIs), there is an urgent need to identify biomarkers to stratify responders and non-responders using programmed death-ligand (PD-L1) expression, and to predict patient-specific outcomes such as progression free survival (PFS). The current stu...
Autores principales: | Yolchuyeva, Sevinj, Giacomazzi, Elena, Tonneau, Marion, Lamaze, Fabien, Orain, Michele, Coulombe, François, Malo, Julie, Belkaid, Wiam, Routy, Bertrand, Joubert, Philippe, Manem, Venkata S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329671/ https://www.ncbi.nlm.nih.gov/pubmed/37422576 http://dx.doi.org/10.1038/s41598-023-38076-y |
Ejemplares similares
-
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023) -
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study
por: Tonneau, Marion, et al.
Publicado: (2023) -
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy
por: Diop, Khoudia, et al.
Publicado: (2023) -
Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021) -
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2022)